NEWHALL CHARLES W III - Insider Non-Derivative Transactions at SUPERNUS PHARMACEUTICALS, INC. (SUPN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 21, 2025, NEWHALL CHARLES W III's relationship to SUPERNUS PHARMACEUTICALS, INC. (SUPN) is Director, and currently has 119,644 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SUPN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

NEWHALL CHARLES W III - Insider Non-Derivative Transactions of SUPN Common Stock

NEWHALL CHARLES W III - Insider Non-Derivative Transactions at SUPN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 22, 2025	M -- (Common Stock)	15000	12.98	119644
Oct 10, 2025	Sell -- (Common Stock)	1200	51.55	104644
Oct 10, 2025	Sell -- (Common Stock)	23800	50.73	105844
Aug 28, 2025	Sell -- (Common Stock)	3588	45.01	129644
Aug 26, 2025	Sell -- (Common Stock)	1000	45	133232
Aug 23, 2025	Sell -- (Common Stock)	1412	45	134232
Feb 23, 2025	Acquisition -- (Common Stock)	5369	0	135644
Nov 12, 2024	Sell -- (Common Stock)	10700	36.24	130275
Nov 12, 2024	M -- (Common Stock)	20000	9.13	140975
Feb 24, 2024	Acquisition -- (Common Stock)	3886	0	120975
Nov 17, 2023	Sell -- (Common Stock)	2500	28.01	117089
Nov 17, 2023	M -- (Common Stock)	7457	9.24	119589
Feb 23, 2023	Acquisition -- (Common Stock)	3882	0	112132
Apr 18, 2018	G -- (Common Stock)	2203	0	108250